FSENX | RYVAX | FSENX / RYVAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 43 years | 27 years | - |
Gain YTD | 10.497 | -4.730 | -222% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 2500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2B | 6.55M | 30,449% |
Annual Yield % from dividends | 1.72 | 0.00 | - |
Returns for 1 year | 11.14 | -1.79 | -623% |
Returns for 3 years | 74.47 | 25.32 | 294% |
Returns for 5 years | 95.98 | 20.07 | 478% |
Returns for 10 years | 31.89 | -68.91 | -46% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SSIQX | 11.23 | -0.02 | -0.18% |
State Street International Stock Sel K | |||
SIEYX | 11.41 | -0.06 | -0.52% |
Saratoga International Equity A | |||
VSCNX | 22.21 | -0.18 | -0.80% |
Natixis Vaughan Nelson Small Cap Value N | |||
FEAAX | 47.08 | -0.59 | -1.24% |
Fidelity Advisor Emerging Asia A | |||
FGRAX | 53.67 | -1.39 | -2.52% |
Franklin Growth Opportunities A |